Por favor, use este identificador para citar o enlazar este ítem:
https://observatorio.fm.usp.br/handle/OPI/23833
Título: | BUPROPION/NALTREXONE FIXED-DOSE COMBINATION FOR THE TREATMENT OF OBESITY |
Autor: | HALPERN, B.; FARIA, A. M.; HALPERN, A. |
Citación: | DRUGS OF TODAY, v.47, n.8, p.575-581, 2011 |
Resumen: | The combination of bupropion and naltrexone is one of the most promising new possibilities for the treatment of obesity in an era of increasing prevalence of this disease and decreasing options for its pharmacological management. Although approved by FDA panel members, it was temporally rejected by the FDA afterwards, who demanded more cardiovascular safety data for its commercialization. This monograph will focus on the physiology involved in its mechanisms of action and results of clinical trials. |
Aparece en las colecciones: | Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - HC/ICr Artigos e Materiais de Revistas Científicas - LIM/42 |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.